Compare Arqit Quantum Inc (ARQQ) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arqit Quantum Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Arqit Quantum Inc trades at $24.3 (market cap $424.79M), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 193.2× Arqit Quantum Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Arqit Quantum Inc pays none. Which is the better fit depends on your goals.
| ARQQ | REGN | |
|---|---|---|
Market Cap | $424.79M | $82.06B |
Sector | Technology | Health |
52-Week High | $58.27 | $812.27 |
52-Week Low | $11.78 | $555.51 |
Enterprise Value | $398.10M | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Arqit Quantum Inc
Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.
Read more on ARQQ →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
